Study Findings on Middle Cerebral Artery Infarction Reported by Researchers at National Health Insurance Service Ilsan Hospital (Recanalization of the middle cerebral artery after prolonged induced hypertensive therapy to rescue early …): Central Nervous System Diseases and Conditions – Middle Cerebral Artery Infarction

2022 JUL 25 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Cardiovascular Daily -- New research on middle cerebral artery infarction is the subject of a new report. According to news reporting out of Goyang, South Korea, by NewsRx editors, research stated, “Although decades have passed since the introduction of pharmacologically induced hypertensive therapy (PIHT) against early neurologic deterioration (END) in acute ischemic stroke, the optimal duration of PIHT remains elusive.”

Our news journalists obtained a quote from the research from National Health Insurance Service Ilsan Hospital: “A 70-year-old man developed right hemiplegia and aphasia 25 hours before arrival. Computed tomography angiography (CTA) revealed acute infarction in the left middle cerebral artery (MCA) territory and occlusion of the left internal carotid artery. He experienced END 36 hours after admission, and CTA revealed a newly developed proximal MCA occlusion. PIHT was initiated to augment cerebral perfusion. As his neurologic symptoms were highly dependent on blood pressure, PIHT was inevitably sustained for over 3 weeks. Follow-up CTA revealed recanalization of the MCA.”

According to the news reporters, the research concluded: “Although further investigation is required to expedite the future clinical application, prolonged PIHT may serve as a viable collateral-enhancing treatment for a certain subset of patients with END without alternative treatment options.”

For more information on this research see: Recanalization of the middle cerebral artery after prolonged induced hypertensive therapy to rescue early neurologic deterioration: a case report. Journal of Neurocritical Care, 2022,15(1):69-75. (Journal of Neurocritical Care - https://www.e-jnc.org). The publisher for Journal of Neurocritical Care is The Korean Neurocritical Care Society.

A free version of this journal article is available at https://doi.org/10.18700/jnc.210036.

Our news editors report that additional information may be obtained by contacting Han Kyu Na, Department of Neurology, National Health Insurance Service Ilsan Hospital, Goyang, South Korea. Additional authors for this research include Taewon Kim, Jung Yon Yum, Woohyun Park, Joonho Kim, Seokhyun Kim, Jong Hun Kim, Kwon-Duk Seo.

(Our reports deliver fact-based news of research and discoveries from around the world.)